Aequus Pharmaceuticals Inc. filed its Annual on Jun 30, 2022 for the period ending Dec 31, 2021. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -20.00% | 0.00% | -20.00% |
1st Jan change | Capi. | |
---|---|---|
-20.00% | 1.94M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- AQS Stock
- News Aequus Pharmaceuticals Inc.
- Aequus Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt